Background/Aims: The atypical retinoid E23-(40-hydroxyl-30-adamantylbiphenyl-4-yl) acrylic acid (ST1926, adarotene) is used in the treatment of malignancy. The effect of ST1926 is at least in part due to stimulation of apoptosis. Similar to apoptosis of nucleated cells, erythrocytes may enter eryptosis, the suicidal death of erythrocytes. Hallmarks of eryptosis include cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Signaling involved in the stimulation of eryptosis includes increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ), oxidative stress and ceramide. The present study explored, whether adarotene induces eryptosis and, if so, to test for the involvement of Ca 2+ entry, oxidative stress and ceramide. Methods: Flow cytometry was employed to estimate phosphatidylserine exposure at the cell surface from annexin-V-binding, cell volume from forward scatter, [Ca 2+ ] i from Fluo3-fluorescence, reactive oxygen species (ROS) formation from DCFDA dependent fluorescence, and ceramide abundance utilizing specific antibodies. Results: A 48 hours exposure of human erythrocytes to adarotene (9 µM) significantly increased the percentage of annexin-V-binding cells, an effect paralleled by significant decrease of forward scatter, as well as significant increase of Fluo3-fluorescence, DCFDA fluorescence, and ceramide abundance. The effect of adarotene (9 µM) on annexin-V-binding was significantly blunted but not abolished by removal of extracellular Ca 2+ . Conclusions: Adarotene stimulates phospholipid scrambling of the erythrocyte cell membrane, an effect paralleled by and at least in part due to Ca 2+ entry, oxidative stress and ceramide.
Introduction
The atypical retinoid E23-(40-hydroxyl-30-adamantylbiphenyl-4-yl) acrylic acid (ST1926, adarotene) counteracts growth of several tumor cells [1, 2] , including rhabdomyo-sarcoma [3] , neuroblastoma [4, 5] , ovarian cancer [6] [7] [8] [9] , teratocarcinoma [10] , chronic myeloid leukemia [11] , acute myeloid leukaemia [12, 13] , and adult T-cell leukemia/lymphoma [14] . ST1926 is at least in part effective by inducing apoptosis [1, 9, 13, 15] .
Similar to apoptosis of nucleated cells, erythrocytes may enter eryptosis, the suicidal death of erythrocytes [16] . The hallmark of eryptosis is cell membrane scrambling with phosphatidylserine translocation to the cell surface [17] . Stimulators of eryptosis include increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ) [17] , ceramide [18] , oxidative stress [17] and energy depletion [17] . Signaling of eryptosis may further involve the G-protein Galphai2 [19] , caspases [17, 20, 21] , as well as activation of casein kinase 1α [17] , Janus-activated kinase JAK3 [17] , protein kinase C [17] , and p38 kinase [17] . Kinases inhibiting eryptosis include AMP activated kinase AMPK [17] , cGMP-dependent protein kinase [17] , PAK2 kinase [17] , mitogen and stress activated kinase MSK1/2 [22] , and sorafenib/sunitinib sensitive kinases [17] . Eryptosis could be triggered by diverse xenobiotics [17, , and enhanced eryptosis is observed in several clinical conditions including iron deficiency [17] , dehydration [76] , hyperphosphatemia [77] , hepatic failure [78] , malignancy [79, 80] , chronic kidney disease (CKD) [81] [82] [83] [84] [85] , hemolytic-uremic syndrome [86] , arteriitis [87] , diabetes [88] , hepatic failure [43] , sepsis [89] , sickle-cell disease [17] , beta-thalassemia [17] , Hb-C and G6PD-deficiency [17] , Wilsons disease [90] as well as advanced age [91] . Eryptosis further increases following storage for transfusion [92] .
The present study tested, whether adarotene is capable to stimulate eryptosis. To this end, human erythrocytes were treated with adarotene and phosphatidylserine abundance at the erythrocyte surface, erythrocyte volume, [Ca 2+ ] i , and ceramide determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 48 hours. Where indicated, erythrocytes were exposed for 48 hours to adarotene (MedChem Express, Princeton, USA), or CaCl 2 was removed and 1 mM EGTA added.
Annexin-V-binding and forward scatter
After incubation under the respective experimental condition, a 150 µl cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 15 min under protection from light. The annexin-Vabundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for untreated and adarotene treated erythrocytes. A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of "52". 
Intracellular Ca
Reactive oxygen species (ROS)
Oxidative stress was estimated utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 150 µl suspension of erythrocytes was washed in Ringer solution and stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and washed two times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Ceramide abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. To this end, cells were stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice with PBS-BSA. The cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. As a control, secondary antibody alone was used.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Results
The present study explored the putative effect of adarotene on eryptosis, the suicidal erythrocyte death.
In a first series of experiments, erythrocyte volume was estimated from forward scatter which was determined utilizing flow cytometry. Prior to measurements, the erythrocytes were incubated for 48 hours in Ringer solution without or with adarotene (3 -9 µM). As illustrated in Fig. 1 , adarotene did not significantly modify the average erythrocyte forward scatter.
In a second series of experiments, phosphatidylserine exposing erythrocytes were identified utilizing annexin-V-binding, as determined by flow cytometry. Prior to measurements, the erythrocytes were again incubated for 48 hours in Ringer solution 
without or with adarotene (3 -9 µM). As illustrated in Fig. 2 ] i ). Prior to measurements, the erythrocytes were again incubated for 48 hours in Ringer solution without or with adarotene (3 -9 µM). As illustrated in Fig. 3A ,B, a 48 hours incubation with adarotene significantly increased Fluo3 fluorescence, an effect reaching statistical significance at 6 µM adarotene Fig. 4C) .
A next series of experiments explored whether the adarotene-induced translocation of phosphatidylserine required entry of extracellular Ca 2+ . To this end, erythrocytes were incubated for 48 hours in the absence or presence of 9 µM adarotene in the presence or nominal absence of extracellular Ca (black bars) Adarotene (3 -9 µM) or solvant DMSO alone (grey bar). ***(p<0.001) indicates significant difference from the absence of Adarotene (ANOVA).
Further triggers of eryptosis include oxidative stress. Thus, the abundance of reactive oxygen species was quantified utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA) fluorescence. As shown in Fig. 5 , a 48 hours exposure to 9 µM adarotene significantly increased the DCFDA fluorescence.
Cell membrane scrambling could further be triggered by ceramide. Ceramide abundance at the erythrocyte surface was thus quantified utilizing specific antibodies. As illustrated in Fig. 6 , a 48 hours exposure to 10 µM adarotene significantly increased the ceramide abundance.
Discussion
The present study reveals that adarotene (ST1926) stimulates erythrocyte cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. The adarotene concentration required for stimulation of cell membrane scrambling was in the range of concentrations encountered in vivo [3] .
The effect of adarotene on cell membrane scrambling was paralleled by a significant increase of average Fluo3 fluorescence indicating that adarotene increased cytosolic Ca . Thus, some additional mechanism must have contributed to the stimulation of cell membrane scrambling following treatment of erythrocytes with adarotene. As a matter of fact, adarotene treatment increased the abundance of reactive oxygen species and of ceramide, which are both known to stimulate cell membrane scrambling [17] .
Adarotene treatment did not significantly modify average forward scatter and did not significantly modifiy the percentage of shrunken and swollen cells. An increase of [Ca 2+ ] i were expected to activate Ca 2+ sensitive K + channels with subsequent K + exit, cell membrane hyperpolarization, Cl -exit and thus cellular loss of KCl with water [17] . The reason, why adarotene failed to trigger cell shrinkage, remained elusive.
Phosphatidylserine exposing erythrocytes are rapidly cleared from circulating blood and stimulation of cell membrane scrambling may thus result in anemia to the extent that the loss of erythrocytes outcasts the formation of new erythrocytes by erythropoiesis [17] . Phosphatidylserine exposing erythrocytes may further impair microcirculation [18, [93] [94] [95] [96] [97] by adherence to the vascular wall [98] , stimulation of blood clotting and triggering of thrombosis [93, 99, 100] .
In conclusion, adarotene triggers cell membrane scrambling, an effect involving Ca 2+ entry and ceramide. 
